Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction

Oral phosphodiesterase inhibitors have emerged as a game changer for the treatment of erectile dysfunction (ED) since attaining FDA approval for its first member, sildenafil, in 1998. Topical penile therapy could be a viable replacement for oral medication that would transform the treatment of ED fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Soad A., Rofaeil, Remon Roshdy, Salem, Hesham, Elrehany, Mahmoud, Asiri, Yahya I., Al Fatease, Adel, Abdelkader, Hamdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453270/
https://www.ncbi.nlm.nih.gov/pubmed/37623052
http://dx.doi.org/10.3390/gels9080597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453270/
https://www.ncbi.nlm.nih.gov/pubmed/37623052
http://dx.doi.org/10.3390/gels9080597

Ejemplares similares